
    
      Data from this study will be used to assess the potential of GSK1292263 as a treatment for
      T2DM, and will aid the design and dose selection of future studies of longer duration in T2DM
      subjects that will evaluate GSK1292263 alone or in combination with other anti-diabetic
      drugs.
    
  